Lorence H. Kim, Chief Financial Officer at Moderna, Inc. (MRNA), sold 39,600 shares at $34.24 ($1.4M) on 2020-04-15, disclosed to the SEC on 2020-04-16.
Open-market sale of $1.4M MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.24 | 6,177 | $212K | 14.8% |
| 2 | $34.24 | 6,177 | $212K | 14.8% |
| 3 | $35.81 | 1,517 | $54K | 3.8% |
| 4 | $35.81 | 1,517 | $54K | 3.8% |
| 5 | $36.57 | 4,566 | $167K | 11.7% |
| 6 | $36.57 | 4,566 |
| $167K |
| 11.7% |
| 7 | $37.62 | 7,340 | $276K | 19.3% |
| 8 | $37.62 | 7,340 | $276K | 19.3% |
| 9 | $38.24 | 400 | $15K | 1.1% |
| Total | $36.19 avg | 39,600 | $1.4M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-25 | $1.0M | — | Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |